NCT07624266

Brief Summary

This study aimed to evaluate the effects of different capillary blood sampling techniques on blood glucose measurement results in people with diabetes. Blood glucose measurements obtained from the first and second capillary blood drops after antiseptic application were compared. In addition, measurements obtained with and without finger squeezing were evaluated. The findings may contribute to improving standardization in capillary blood glucose monitoring procedures and reducing unnecessary repeated finger punctures in clinical practice.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 19, 2026

Completed
15 days until next milestone

First Posted

Study publicly available on registry

June 3, 2026

Completed
Last Updated

June 3, 2026

Status Verified

May 1, 2026

Enrollment Period

6 months

First QC Date

May 19, 2026

Last Update Submit

May 31, 2026

Conditions

Keywords

Blood glucose monitoringCapillary blood samplingFirst blood dropFinger squeezingGlucometerSelf-monitoring of blood glucose

Outcome Measures

Primary Outcomes (2)

  • Difference between blood glucose measurements obtained with and without finger squeezing

    Comparison of blood glucose values obtained from capillary blood samples collected with and without finger squeezing. Blood glucose measurements were obtained consecutively during a single study visit (Day 1), first from a capillary blood sample collected without finger squeezing and subsequently from a capillary blood sample collected with finger squeezing during the same blood sampling and measurement session

    Day 1

  • Difference between blood glucose values obtained from the first and second capillary blood drops following antiseptic application

    Comparison of blood glucose values obtained from the first and second capillary blood drops after antiseptic application. The first and second blood drop measurements were obtained consecutively during the same capillary blood sampling and measurement session.

    Day 1

Interventions

Blood glucose measurements obtained from the first and second capillary blood drops and measurements performed with and without finger squeezing were compared using the same glucometer device under standardized clinical conditions.

Also known as: Capillary Blood Glucose Measurement Procedures

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults with diabetes who were hospitalized in the internal medicine clinics of a state hospital during the study period and met the study inclusion criteria.

You may qualify if:

  • Aged 18 years or older
  • Diagnosed with diabetes mellitus
  • Provided written and verbal informed consent to participate in the study
  • Eligible for blood glucose measurement after at least 6 hours of fasting
  • No condition preventing capillary blood sampling from the fingertip
  • Physically and mentally able to undergo the measurement procedures specified in the study

You may not qualify if:

  • Presence of a physical disability or deformity affecting fingertip blood glucose measurement
  • Presence of coagulation disorders (e.g., hemophilia) or severe medical conditions affecting blood sampling
  • Use of steroids within the previous 24 hours that could affect blood glucose levels
  • Presence of physical or mental conditions limiting compliance with study procedures
  • Inability or unwillingness to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ordu Univercıty

Altinordu, Ordu, 52200, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 19, 2026

First Posted

June 3, 2026

Study Start

February 1, 2025

Primary Completion

July 30, 2025

Study Completion

December 30, 2025

Last Updated

June 3, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be publicly available due to confidentiality and privacy considerations. However, statistical data may be provided by the corresponding author upon reasonable request.

Locations